People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
She was happily married, pregnant with her first child and had recently completed her residency in family medicine. Soon ...
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
Taryn Robertson, a professor at Randolph College, is currently fundraising and training to run a marathon for her father who ...
Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...
Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...
A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...
New report from The National Alliance for Caregiving, in partnership with The Michael J. Fox Foundation and Arcadia University , examines complexities of Parkinson's caregiving ...
A Swindon man with Parkinson's disease will skydive from 15,000 feet to raise awareness and funds for charity.
Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback